Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Science

• Publication date

  2000-12-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1126/SCIENCE.290.5500.2303PMID 11125143
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Robust LOD scores for variance component‐based linkage analysis

  2000cited by this paper
• Susceptibility locus for Alzheimer's disease on chromosome 10.

  2000cited by this paper
• Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

  2000cited by this paper
• A full genome scan for late onset Alzheimer's disease.

  1999cited by this paper
• Multipoint quantitative-trait linkage analysis in general pedigrees.

  1998cited by this paper
• A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2

  1997cited by this paper
• Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

  1996cited by this paper
• Indication for Linkage of the Human OB Gene Region With Extreme Obesity

  1996cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

  1996cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Quantitative trait locus for reading disability on chromosome 6.

  1994cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

  1993cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

  1992cited by this paper

• A Randomized Clinical Trial Reveals Effects of Mindfulness and Slow Breathing on Plasma Amyloid Beta Levels

  2025cites this paper
• Daily mindfulness practice with and without slow breathing has opposing effects on plasma amyloid beta levels

  2025cites this paper
• Heart rate and breathing effects on attention and memory (HeartBEAM): study protocol for a randomized controlled trial in older adults

  2024cites this paper
• Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients

  2022cites this paper
• Applications and Challenges of Machine Learning Methods in Alzheimer's Disease Multi-Source Data Analysis

  2021cites this paper
• Mechanistic roles for altered O-GlcNAcylation in neurodegenerative disorders.

  2021cites this paper
• Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism

  2021cites this paper
• Ginsenoside Rb1 Improves Cognitive Impairment Induced by Insulin Resistance through Cdk5/p35-NMDAR-IDE Pathway

  2020cites this paper
• Optic Nerve

  2020cites this paper
• Modelling the neuroanatomical progression of Alzheimer's disease and posterior cortical atrophy

  2020cites this paper
• Plasma Aβ42 and Total Tau Predict Cognitive Decline in Amnestic Mild Cognitive Impairment

  2019cites this paper
• Modelling mitochondrial dysfunction in Alzheimer’s disease using human induced pluripotent stem cells

  2019cites this paper
• WISARD: workbench for integrated superfast association studies for related datasets

  2018cites this paper
• Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer’s disease: possible mechanisms of IDE in T2D and AD

  2017cites this paper
• Amyloid beta: structure, biology and structure-based therapeutic development

  2017cites this paper
• Design, Synthesis and Biological Assessment of Ferulic Acid Derivatives as Inhibitors of β-Amyloid Oligomerization in Alzheimer’s Disease

  2017cites this paper
• Unraveling the genes implicated in Alzheimer's disease.

  2017cites this paper
• Effects of Aluminium on Long‐Term Memory in Rats and on SIRT1 Mediating the Transcription of CREB‐Dependent Gene in Hippocampus

  2017cites this paper
• Contribution à l'étude de la maladie d'Alzheimer : induction de la production d'amyloïdes beta-42/43 par le fipronil, un pesticide de la famille des phenylpyrazoles : effets cellulaires des Leucettines, une famille d'inhibiteurs des kinases DYRKs/CLKs

  2017cites this paper
• Neurodegenerative Diseases and Dementia

  2016cites this paper
• Polymorphisms of CHAT but not TFAM or VR22 are Associated with Alzheimer Disease Risk

  2016cites this paper
• Type 2 Diabetes, Obesity, and Risk for Dementia: Recent Insights into Brain Insulin Resistance and Hypometabolism

  2016cites this paper
• Role of ROS and RNS Sources in Physiological and Pathological Conditions

  2016cites this paper
• Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic.

  2016cites this paper
• Therapeutic Targeting of Aβ42

  2016cites this paper
• Mouse Models for Drug Discovery

  2016cites this paper
• Association Between Polymorphisms of the Insulin-Degrading Enzyme Gene and Late-Onset Alzheimer Disease

  2015cites this paper
• Child and Adolescent Psychiatry.

  2015cites this paper
• 13 – Optic Nerve

  2015cites this paper
• Beta-Amyloid-orientierte Therapien der Alzheimer-Krankheit

  2015cites this paper
• A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease*

  2014cites this paper
• A CTNNA3 compound heterozygous deletion implicates a role for αT-catenin in susceptibility to autism spectrum disorder

  2014cites this paper
• A genome-wide association meta-analysis of plasma Aβ peptides concentrations in the elderly

  2014cites this paper
• GWAS, Cytomegalovirus Infection, and Schizophrenia

  2014cites this paper
• APP Identification of APP : Gene and Protein Structure

  2014cites this paper
• Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations.

  2014cites this paper
• Plasma insulin-degrading enzyme: Characterisation and evaluation as a potential biomarker for Alzheimer's disease

  2014cites this paper
• Other Genes Implicated in Alzheimer’s Disease

  2013cites this paper
• Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N‐acetyl‐L‐cysteine

  2013influential citation
• KIAA1462, A Coronary Artery Disease Associated Gene, Is a Candidate Gene for Late Onset Alzheimer Disease in APOE Carriers

  2013cites this paper
• LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)

  2013cites this paper
• Evidence of recessive Alzheimer disease loci in a Caribbean Hispanic data set: genome-wide survey of runs of homozygosity.

  2013cites this paper
• Can a combination of nutritional components decrease neuroinflammation in Alzheimer ’ s disease , thereby altering its development ?

  2013cites this paper
• Meta-Analysis of the Association Between Urokinase-Plasminogen Activator Gene rs2227564 Polymorphism and Alzheimer’s Disease

  2013cites this paper
• The role of choline acetyltransferase variants in Alzheimer's disease models

  2013cites this paper
• Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease

  2013cites this paper
• GWAS with AHP based SNP prioritization approach to identify SNP biomarkers for Alzheimer's disease

  2012cites this paper
• Collection of Clinical and Epidemiological Data for Genetic Linkage and Association Studies

  2012cites this paper
• Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease

  2012cites this paper
• Genetic determinants of neuronal vulnerability to apoptosis

  2012cites this paper
• Disclosure of a fundamental clue for the elucidation of the myricetin mechanism of action as amyloid aggregation inhibitor by mass spectrometry

  2012cites this paper
• Production d'un peptide antigénique par l'insulin-degrading enzyme

  2012cites this paper
• Genetics of Alzheimer's disease.

  2012cites this paper
• The association between two single nucleotide polymorphisms within the insulin-degrading enzyme gene and Alzheimer's disease in a Chinese Han population.

  2012cites this paper
• Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.

  2012cites this paper
• Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2

  2012cites this paper
• Synaptic dysfunction in Alzheimer's disease.

  2012cites this paper
• IDENTIFICATION AND INVESTIGATION OF γ-SECRETASE ASSOCIATED PROTEINS FROM BRAIN

  2012cites this paper
• Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis

  2012cites this paper
• LRRTM3 is Dispensable for Amyloid-β Production in Mice

  2012cites this paper
• Can cytogenetics explain the possible association between exposure to extreme low‐frequency magnetic fields and Alzheimer's disease?

  2012cites this paper
• DETERMINATION OF PERFORMANCE PARAMETERS FOR AHP BASED SINGLE NUCLEOTIDE POLYMORPHISM (SNP) PRIORITIZATION APPROACH ON ALZHEIMERS'S DISEASE DATA

  2011cites this paper
• Investigating the role of

  2011cites this paper
• Author ' s personal copy Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer ’ s disease : The VITA and Milano studies

  2011cites this paper
• [The role of biological sciences in understanding the genesis and a new therapeutic approach to Alzheimer's disease].

  2011cites this paper
• I SULI RESISTA CE A D COG ITIO : APPROACH FOR TREATI

  2011cites this paper
• Zinc and Zinc Transport and Sequestration Proteins in the Brain in the Progression of Alzheimer’s Disease

  2011cites this paper
• Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene

  2011cites this paper
• Genomics and bioinformatics strategies in the study of aging and Alzheimer disease

  2011cites this paper
• No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease.

  2011cites this paper
• Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease

  2011cites this paper
• Genetic Risk Factors for Dementia

  2011cites this paper
• Identification of genetic influences in late-onset Alzheimer's disease (LOAD)

  2011cites this paper
• ISULIRESISTACE AD COGITIO : EW APPROACH FOR TREATIG ALZHIEMER'S

  2011cites this paper
• Sirtuins as Novel Targets for Alzheimer's Disease and Other Neurodegenerative Disorders: Experimental and Genetic Evidence

  2010cites this paper
• Genome-wide association study of persistent developmental stuttering

  2010cites this paper
• and APOE in Alzheimer's disease -T catenin gene (VR22) α Interaction between the

  2010cites this paper
• The FAS gene, brain volume, and disease progression in Alzheimer's disease

  2010cites this paper
• Examination of the current top candidate genes for AD in a genome-wide association study

  2010cites this paper
• Fine mapping of the chromosome 10q11-q21 linkage region in Alzheimer's disease cases and controls

  2010cites this paper
• Aging-Related Memory Disorders: Alzheimer's Disease

  2010cites this paper
• A Serial Analysis of Gene Expression Profile of the Alzheimer’s Disease Tg2576 Mouse Model

  2010cites this paper
• Genetics of Alzheimer's Disease: Lessons Learned in Two Decades

  2010cites this paper
• Genes associated with Alzheimer Disease

  2010cites this paper
• CALHM1 P86L Polymorphism is Associated with Late-Onset Alzheimer's Disease in a Recessive Model

  2010cites this paper
• Solid state NMR investigations of lipid bilayers and biomembrane binding molecules: Dendrimers and amylin

  2010cites this paper
• Palmitic acid and docosahexaenoic acid opposingly regulate the expression of insulin-degrading enzyme in neurons.

  2010cites this paper
• Genetic Targeting Aromatase in Male Amyloid Precursor Protein Transgenic Mice Down-Regulates β-Secretase (BACE1) and Prevents Alzheimer-Like Pathology and Cognitive Impairment

  2010cites this paper
• Small-Molecule Activators of Insulin-Degrading Enzyme Discovered through High-Throughput Compound Screening

  2009cites this paper
• ApoE 4 reduces the expression of Abeta degrading enzyme IDE by activating the NMDA receptor in hippocampal neurons.

  2009cites this paper
• An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3

  2009cites this paper
• High Serum Aβ and Vascular Risk Factors in First-Degree Relatives of Alzheimer’s Disease Patients

  2009cites this paper
• A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease.

  2009cites this paper
• Identifikation und funktionelle Charakterisierung genetischer Risikofaktoren der Alzheimer Krankheit

  2009cites this paper
• Association analysis of dynamin‐binding protein (DNMBP) on chromosome 10q with late onset Alzheimer's disease in a large caucasian UK sample

  2009cites this paper
• Modeling Sporadic Alzheimer's Disease: The Insulin Resistant Brain State Generates Multiple Long-Term Morphobiological Abnormalities Including Hyperphosphorylated Tau Protein and Amyloid-β

  2009cites this paper
• PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.

  2009cites this paper
• A Potential Role for Alterations of Zinc and Zinc Transport Proteins in the Progression of Alzheimer's Disease

  2009cites this paper
• Yeast Ste23p shares functional similarities with mammalian insulin‐degrading enzymes

  2009cites this paper
• Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure

  2009cites this paper